CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment
Dal Yong Kim, Dae Ho Lee, Sun-Joo Jang, Sang-We Kim, Cheolwon Suh, Jung Shin Lee
Cancer Research and Treatment. 2011;43(4):212-216.   Published online 2011 December 27    DOI: https://doi.org/10.4143/crt.2011.43.4.212

Excel Download

Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment
Cancer Research and Treatment. 2011;43(4):212-216   Crossref logo
Link1

P-29 Phase II study of irinotecan plus docetaxel in previously treated non-small cell lung cancer (NSCLC) patients: preliminary results. An Alpe Adria thoracic oncology multidisciplinary group study (ATOM 007)
Lung Cancer. 2003;41:S98   Crossref logo
Link1 Link2

Randomized phase II study of docetaxel plus cisplatin versus docetaxel plus irinotecan in advanced non-small-cell lung cancer. A West Japan Thoracic Oncology Group Study
Lung Cancer. 2000;29(1):23   Crossref logo
Link1 Link2

Phase II and Phase III Trials: Docetaxel/Irinotecan versus Docetaxel/Cisplatin in Advanced Non–Small-Cell Lung Cancer (WJTOG 9803)
Clinical Lung Cancer. 2001;2(3):178-179   Crossref logo
Link1 Link2

Late phase II clinical study of RP56976 (docetaxel) in patients with non-small cell lung cancer
Lung Cancer. 1995;12(3):308   Crossref logo
Link1 Link2

Late phase II trial of RP 56976 (docetaxel) in patients with non-small-cell lung cancer
Lung Cancer. 1995;13(1):99   Crossref logo
Link1 Link2

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer
Lung Cancer. 1995;13(1):96   Crossref logo
Link1 Link2

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer
Lung Cancer. 1995;12(1-2):152   Crossref logo
Link1 Link2

Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study
Lung Cancer. 2003;39(2):201-207   Crossref logo
Link1 Link2

O-4 A randomized phase II study of docetaxel versus docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first line chemotherapy
Lung Cancer. 2003;41:S5   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.